Kwang Dong Pharmaceutical Co., Ltd. (KRX: 009290)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,680.00
+10.00 (0.18%)
Dec 17, 2024, 3:30 PM KST

Kwang Dong Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Other Revenue
----0--
Upgrade
Revenue
1,634,1981,514,4541,431,5451,338,1821,243,7701,238,255
Upgrade
Revenue Growth (YoY)
8.23%5.79%6.98%7.59%0.45%4.92%
Upgrade
Cost of Revenue
1,337,5951,216,5631,151,5501,065,870987,672981,702
Upgrade
Gross Profit
296,602297,891279,995272,312256,098256,553
Upgrade
Selling, General & Admin
244,068233,331225,167213,458196,462201,578
Upgrade
Research & Development
14,19815,2759,6788,3225,9575,339
Upgrade
Other Operating Expenses
2,4221,9891,3911,5892,8572,655
Upgrade
Operating Expenses
269,905255,821241,751227,376209,507214,750
Upgrade
Operating Income
26,69742,07038,24444,93646,59141,803
Upgrade
Interest Expense
-9,382-6,904-3,735-2,544-2,539-3,177
Upgrade
Interest & Investment Income
7,4855,3992,8442,4152,8502,615
Upgrade
Earnings From Equity Investments
-569.43-429.82-435.51-112.22-62.65-41.36
Upgrade
Currency Exchange Gain (Loss)
-159.44-384.816.49693.27-800.071,051
Upgrade
Other Non Operating Income (Expenses)
-289.28-179.121,132-865.71932.94-895.86
Upgrade
EBT Excluding Unusual Items
23,78239,57138,05644,52246,97241,355
Upgrade
Gain (Loss) on Sale of Investments
24,8219,412-1,932-10,23217,536548.99
Upgrade
Gain (Loss) on Sale of Assets
999.73-1,964166.5238.871,178277.76
Upgrade
Asset Writedown
-----2,735-5,412
Upgrade
Pretax Income
51,60249,01936,29134,32962,95136,770
Upgrade
Income Tax Expense
16,5059,6489,5908,78817,34914,114
Upgrade
Earnings From Continuing Operations
35,09739,37226,70125,54145,60222,656
Upgrade
Minority Interest in Earnings
-1,225-2,406-2,527-1,522-232.19402.51
Upgrade
Net Income
33,87336,96624,17424,01945,37023,058
Upgrade
Net Income to Common
33,87336,96624,17424,01945,37023,058
Upgrade
Net Income Growth
-12.20%52.91%0.64%-47.06%96.76%3.19%
Upgrade
Shares Outstanding (Basic)
404041414140
Upgrade
Shares Outstanding (Diluted)
404041414140
Upgrade
Shares Change (YoY)
-1.58%-1.48%-0.11%1.48%2.24%-2.29%
Upgrade
EPS (Basic)
845.14913.39588.45584.681119.49581.72
Upgrade
EPS (Diluted)
844.84913.00588.00584.331119.00581.72
Upgrade
EPS Growth
-10.72%55.27%0.63%-47.78%92.36%5.61%
Upgrade
Free Cash Flow
-76,044-46,51537,43931,14517,56616,648
Upgrade
Free Cash Flow Per Share
-1897.32-1149.35911.36757.27433.44420.00
Upgrade
Dividend Per Share
100.000100.000100.000100.000100.00080.000
Upgrade
Dividend Growth
0%0%0%0%25.00%0%
Upgrade
Gross Margin
18.15%19.67%19.56%20.35%20.59%20.72%
Upgrade
Operating Margin
1.63%2.78%2.67%3.36%3.75%3.38%
Upgrade
Profit Margin
2.07%2.44%1.69%1.79%3.65%1.86%
Upgrade
Free Cash Flow Margin
-4.65%-3.07%2.62%2.33%1.41%1.34%
Upgrade
EBITDA
40,26954,97452,26259,04566,29960,605
Upgrade
EBITDA Margin
2.46%3.63%3.65%4.41%5.33%4.89%
Upgrade
D&A For EBITDA
13,57212,90414,01714,11019,70918,802
Upgrade
EBIT
26,69742,07038,24444,93646,59141,803
Upgrade
EBIT Margin
1.63%2.78%2.67%3.36%3.75%3.38%
Upgrade
Effective Tax Rate
31.98%19.68%26.43%25.60%27.56%38.38%
Upgrade
Advertising Expenses
-46,18642,21440,46437,87244,725
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.